The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: methylprednisolone     Quarter: 2016Q3

Total Records: 857     Number of Pages: 43

DRUGNAME PT EventCount
METHYLPREDNISOLONE. Diabetes mellitus 12
METHYLPREDNISOLONE. Essential tremor 12
METHYLPREDNISOLONE. Graft versus host disease in skin 12
METHYLPREDNISOLONE. Intentional product use issue 12
METHYLPREDNISOLONE. Maternal exposure during pregnancy 12
METHYLPREDNISOLONE. Nocardiosis 12
METHYLPREDNISOLONE. Stupor 12
METHYLPREDNISOLONE. Chest discomfort 11
METHYLPREDNISOLONE. Platelet count decreased 11
METHYLPREDNISOLONE. Adenovirus infection 10
METHYLPREDNISOLONE. Complications of transplanted kidney 10
METHYLPREDNISOLONE. Dizziness 10
METHYLPREDNISOLONE. Foetal growth restriction 10
METHYLPREDNISOLONE. Herpes zoster 10
METHYLPREDNISOLONE. Human herpesvirus 6 infection 10
METHYLPREDNISOLONE. Hydronephrosis 10
METHYLPREDNISOLONE. Polyomavirus-associated nephropathy 10
METHYLPREDNISOLONE. Condition aggravated 9
METHYLPREDNISOLONE. Cytomegalovirus viraemia 9
METHYLPREDNISOLONE. Epstein-Barr virus infection 9

Total Records: 857     Number of Pages: 43